Brief depression screening questionnaires were found to be valid in primary care in this low-income country. However, these questionnaires do not have immediate applicability in routine clinical settings. Further studies should evaluate utility of indicated screening embedded within health system changes that support MDD detection. Investigation of irritability as a core depression symptom is warranted.
Abstract
Background Brief depression screening questionnaires may increase detection of depression in primary care settings but there have been few validation studies carried out in typical populations in low-income countries.
Methods
Cultural validation of the Patient Health Questionnaire (PHQ-9/ PHQ-2), the 20-item Self-Reporting Questionnaire (SRQ-20) and the Kessler scales (K6/ K10) was carried out in 306 adults consecutively attending primary care facilities in small towns in Ethiopia. To assess criterion validity, the gold standard assessment for presence of Major Depressive Disorder (MDD) was made by Ethiopian psychiatric nurses using the Mini International Neuropsychiatric Interview.
Results
The prevalence of gold standard MDD was 5.9%, with irritability more common than depressed mood or anhedonia. The area under the receiver operating characteristic curve indicated good performance of the PHQ-9, SRQ-20, K6 and K10 (0.83 to 0.85) but only fair for the PHQ-2 (0.78). No cut-off score had acceptable sensitivity combined with adequate positive predictive value. All screening questionnaires were associated with disability and the PHQ-9 and SRQ-20 were associated with higher health service contacts, indicating convergent validity. Construct validity of all scales was indicated by unidimensionality on exploratory factor analysis.
Limitations
Test-retest reliability was not assessed.
Conclusions

Introduction
The treatment gap for depression in low-and middle-income countries (LMICs) is large; in the World Mental Health Survey in China and Nigeria, fewer than 10% of people with depression had received treatment in the year of illness onset [1] .
Undetected depression in rural low-income country community settings has been associated with substantial disability, premature mortality and increased attendance at health facilities with somatic complaints [2] . Non-detection of depression in primary healthcare (PHC) settings is associated with cost and time burdens to both patient and health system due to repeated attendance, inappropriate prescribing of non-evidencebased interventions and poorer prognosis of co-morbid physical health conditions [3] .
Effective treatments for depression that are appropriate and feasible for LMICs exist [4, 5] but are not available to the majority of the population [6] . In order to reduce the treatment gap for depression, the World Health Organization's 'mental health gap action programme' (mhGAP) advocates integration of mental health care into PHC services through task sharing, supported by new evidence-based treatment guidelines suitable for PHC workers [7, 8] . Depression is a priority disorder for mhGAP; however, for successful implementation, increased community awareness and demand for care needs to be coupled with improved detection of depression within PHC.
In high-income countries, accurate detection of depression in PHC is more likely in the presence of a good therapeutic relationship, greater clinical experience, frequent patient contacts and when the patient presents with psychological, rather than somatic, symptoms of depression [9] . This presents a great challenge in LMICs where the PHC system is often weak, with over-burdened clinics and high turnover of staff who have relatively limited training and clinical experience. In addition, somatic presentations of depression are the norm in this setting [10] . Improving detection of depression by PHC workers is challenging [11] . In highincome countries, stand-alone training is ineffective and the use of brief, screening questionnaires for depression are only effective in improving recognition, treatment and outcomes of depression if applied in conjunction with organisational changes, such as collaborative care [12, 13] . However, in low-income countries brief depression screening tools may have greater utility.
In this paper we present the cultural validation of brief questionnaires for detecting depression in PHC settings in Ethiopia. The objective was to examine the potential application of such questionnaires to the implementation and evaluation of mental health care integrated into primary care in Ethiopia as part of the Programme for Improving Mental health CarE (PRIME) [14] .
Material and methods
Study design
A validation study to investigate the criterion, convergent and construct validity of brief depression screening questionnaires.
Setting
The study was carried out in health centres located in and around Butajira town, 130km south of the capital city, Addis Ababa, Ethiopia. A psychiatric nurse-led unit is located in the Zonal hospital in Butajira town. However, at the time of the study there was no mental health care available in PHC. The PHC facility is staffed by health officers and nurses. This validation study was carried out in one urban, two semiurban and one rural health centre, selected purposively.
Brief questionnaires to detect depression
(1) Self Reporting Questionnaire, 20-item version (SRQ-20) [15] The SRQ-20 was developed to improve detection of common mental disorders in PHC settings in LMICs [15] . The SRQ items are single-clause questions which require a yes/no response and are easily administered in an interview format. The items include somatic, anxiety and depressive symptoms, as well as questions about suicidal ideation and functional impact, present in the preceding 30 days. The SRQ-20 has been widely validated and used in LMICs. In Ethiopia, the SRQ-20 has been validated for detection of depression in postnatal women [16, 17] . A culturally adapted version of SRQ ('SRQ-F') lengthened the scale with little improvement in psychometric properties [18] .
(2) Kessler 6 and 10 item versions (K6/ K10) [19] The K10 and K6 scales are widely used tools to assess non-specific psychological distress in the previous one month. Each item is rated from 1 to 5, based on the persistence of a specific symptom, from "none at all" to "all the time". The K10 scale includes depressive, anxiety and somatic symptoms but not suicidal ideation. The Kessler 6-item scale comprises a sub-set of the Kessler 10-item scale (items 2, 3, 5, 7, 9 and 10). In Ethiopia, the criterion validity of K6 and K10 for detection of depression in postnatal women has been demonstrated [17] but the Kessler has not been evaluated in a general PHC setting.
(3) Patient Health Questionnaire, 2-and 9-item versions (PHQ-2 [20] and PHQ-9
The PHQ-9 is a widely used depression screening scale for PHC in high-income countries. The nine items of the PHQ follow the Diagnostic and Statistical Manual (DSM) version IV [22] diagnostic criteria for a depressive episode, including suicidal ideation, and ask about symptoms present in the preceding two weeks. The four response categories refer to the amount of time that the symptom was present (from 'not at all' (0) to 'nearly every day' (3)). A tenth item asks about the functional impact of the symptoms. Responses to the PHQ-9 can be summed to give a total symptom score. Alternatively, the DSM diagnostic algorithm for a major depressive episode can be applied to give a categorical diagnosis of depression. The PHQ-2 is comprised of the first two items of the PHQ-9 and has been found to be a useful screener in PHC settings in high-income countries [20] . The criterion validity of the PHQ-9 for detecting depression has been demonstrated in medical out-patients at a referral hospital in Addis Ababa, Ethiopia [23] .
Semantic, technical and content validation
Semantic, technical and content validity in the Ethiopia setting have already been established for the Amharic versions of the SRQ-20 [16, 24] and K10 [17] . The PHQ-9 was translated independently into Amharic by two Ethiopian psychiatrists and then back-translated into English. The final version was obtained by expert consensus.
Moving from a self-completed to an interviewer-administered questionnaire necessitated modifications, in keeping with previous studies from low-income countries [25] . See Supplementary Files 1 and 2.
Criterion, construct and convergent validation study Sample
Consecutive patients attending the four PHC facilities were recruited over a three
week period in March 2013. Patients were approached after they had consulted the PHC worker. Patients were excluded if they required emergency medical attention, were unable to converse in Amharic (the official language of Ethiopia), were unable to communicate or were suffering from severe mental disorder.
Procedure
Participants were interviewed by (1) lay data collectors who administered the brief depression scales (SRQ-20, K10/K6 and PHQ-9/PHQ-2) and other structured questionnaires (see below), and (2) psychiatric nurses who carried out a gold standard clinical assessment to determine the presence or absence of MDD. To overcome order effects, the administration of the scales and assessments was randomised. Psychiatric nurses and lay data collectors were each masked to the outcome of the other assessment.
Gold standard measure of depression
The MINI is a structured diagnostic assessment scale that allows DSM-IV and ICD-10 diagnosis [26] and has been widely used as a gold standard measure of MDD [27] .
Adaptations to the MINI MDD module were made in order to improve sensitivity to sociocultural expressions of distress. The skip rules were not applied and raters were allowed to explore symptoms once the fully-structured probe questions had been asked. A question on irritability was added, based on previous qualitative work and clinical experience that indicate this is an important manifestation of depression in the setting. After administering the MINI, combined with information gleaned from further clinical interview and observation, and considering bereavement and organic exclusion criteria, the psychiatric nurses gave their overall clinical judgment as to whether the person was suffering from MDD.
Other measures
The convergent validity of the brief depression scales was evaluated by examining the association with frequency of health service use in the preceding three months and functional impairment. The World Health Organization Disability Assessment Schedule, version 2 (WHODAS 2.0) [28] assesses both the level of functional impairment and the number of days lost from work in the previous 30 days due to a health condition. The instrument is considered to be cross-culturally applicable and the Amharic version has been used in Ethiopia previously [29] .
Sociodemographic characteristics (age, sex, marital status, educational level, area of residence and occupation) were measured using structured self-report questions..
Participants were also asked systematically about their main reasons for seeking help from the health centre and the diagnosis that the health worker had given them.
Training
The lay-interviewers were all high school completers who are experienced data collectors in the field of mental health. The lay data collectors were trained for four days by senior mental health researchers, followed by one day of observed pilot interviews.
Three psychiatric nurses were trained by an Ethiopian psychiatrist for two days in administration of the criterion measure (MINI). The training included extensive role play and observed piloting of the gold standard assessment.
Sample size
A formula for calculating sensitivity and specificity for single tests was used [30] . The assumptions used for calculating sample size were as follows: anticipated sensitivity 80%, alpha 0.05, L (desired precision) = 0.1, Z 2 1-α/2= 3.84, prevalence = 20% and loss due to incomplete data or other reasons=3%. The required sample size was 316, to allow calculation of the sensitivity estimate within the confidence limits of 75% and 84%.
Data management and quality assurance
Data were checked for completeness in the field by supervisors and entered on the day of data collection where possible. Double data entry with consistency checks was carried out using EpiData [31] . An Ethiopian psychiatrist supervised the psychiatric nurse assessments. An experienced supervisor observed selected lay interviewer assessments.
Data analysis
Data analysis was carried out using Stata version 13.1 [32] . Receiver Operating Characteristic (ROC) curves were plotted. Optimal cut-off scores were identified on the basis of the maximum specificity which was not higher than sensitivity. Internal consistency was evaluated using Cronbach's alpha [33] . At the optimal cut-point, sensitivity, specificity, positive and negative predictive values, percentage correct classification, Cohen's kappa and Youden's index (sensitivity + specificity -1) [34] were calculated.
The prevalence ratio for individual depression screening scale items in people with MDD vs. people without MDD was calculated using a poisson working model and sandwich estimators of the standard errors [35] . Items on the PHQ-9 were dichotomised as 0/1 vs. 2/3, and items on the Kessler were dichotomised as 1/3 vs. Construct validity of the depression screening scales was investigated using exploratory factor analysis with maximum likelihood extraction and varimax rotation.
Inspection of eigenvalues and scree plots was used to identify the number of factors to be retained as indicators of scale dimensions. As the SRQ-20 has dichotomous response categories, tetrachoric correlation matrices were used as the basis for factor analysis.
In order to investigate misclassification of MDD by the screening scales, a multivariable logistic regression analysis was carried out with each scale score dichotomised at the optimal cut-off score for detection as the dependent variable. By including the gold standard diagnosis of MDD as an independent variable, all other associations with the dependent variable were indicative of misclassification. The following items were identified as being potentially associated with misclassification of MDD: age, sex [36] , education, rural vs. urban residence and two items on the WHODAS 2.0 ("difficulty standing for long periods" and "difficulty walking long distances") that were more indicative of physical than mental disability [37] .
Ethical considerations
The investigation was carried out in accordance with the latest version of the Declaration of Helsinki, the study design was reviewed by the Institutional Review
Board of the College of Health Sciences, Addis Ababa University and informed consent of the participants was obtained after the nature of the procedures had been fully explained. All persons identified by the psychiatric nurses as suffering from mental disorder were offered appropriate treatment and follow-up with the existing Butajira psychiatric service.
Results
A total of 309 adults were recruited into the study. There were no refusers. Data were missing for three participants, giving a final sample of 306. The socio-demographic characteristics of participants are described in Table 1 .
[ Table 1 ]
Gold standard MDD
The prevalence of major depressive disorder was 5.9% (n=18) according to the gold standard psychiatric nurse assessment using the MINI. Only 11 out of 18 people with MDD had either of the core DSM-IV depression symptoms (depression or anhedonia); however a further six cases of MDD had mood change in the form of irritability ("being easily angry or upset"). Overall, 14/18 cases of MDD had irritability (19/286 for non-cases), 9/18 of cases had depressed mood (4/284 noncases) and 8/18 of cases had anhedonia (7/287 non-cases).
None of the participants with MDD reported any emotional symptoms as being their primary reason for seeking help; however, sleep and appetite problems and 'anxiety'
and 'depressed mood' were reported as secondary reasons for attendance (n=3). Two participants were undergoing voluntary testing and counselling for HIV, one was attending antenatal care and the remainder presented with abdominal complaints (n=5), headache (n=4), burning sensations, palpitations, cough, and toothache (n=1 each). The majority of participants reported that the PHC workers had not informed them of the diagnosis. None had been given a diagnosis of MDD by the PHC worker.
Depression screening scales
The frequency distributions for all of the depression scales were negatively skewed.
The median scores (25 th and 75 th centiles) were as follows: PHQ-9: 12 (10, 18), PHQ-2: 6 (6, 10), SRQ-20: 3 (1, 8), K10: 12 (10, 18) and K6: 6 (6, 10). There was no evidence of ceiling effects, but possible floor effects for the PHQ-2 (58.2% of participants scored 0 out of 6) and Kessler scales (52.3% scored the minimum score on the K6 and 42.2% for the K10). Internal consistency, as indicated by Cronbach's alpha, was good (0.84 for PHQ-9, 0.90 for SRQ-20, 0.88 for K10 and 0.85 for K6).
Criterion validity
See Figure 1 .
[ Figure 1 ]
Apart from the PHQ-2, the optimal scale cut-off scores for indicating probable MDD for the other scales had Youden's scores > 0.50 and correct classification in around three-quarters of cases; however, the positive predictive value at these cut-off scores was very low: under 18% for all scales and only 11.7% for the PHQ-2. See Supplementary Table 1 .
[ Table 2 ]
When the cut-off score was increased so that the PPV was at least 50%, as per recommendations for useful depression scales in PHC settings [38] , this led to an unacceptable drop in sensitivity. The agreement between the brief screening scales and the gold standard was only moderate, as indicated by the kappa scores which clustered around 0.20.
Applying the DSM-IV diagnostic algorithm to the PHQ item responses, 2.9% (n=9)
fulfilled criteria for MDD. The PHQ algorithmic diagnosis of MDD had very low sensitivity (22.0%) and low PPV (44.0%).
Most of the individual items on each of the depression screening scales were significantly more prevalent in people with MDD compared to those without MDD.
See Table 3 .
[ Table 3 ]
The prevalence ratios for items in the PHQ-9 were higher than for most of the other scales, in particular when compared to the SRQ-20. Somatic symptoms tended to discriminate less well than cognitive symptoms between people with and without MDD.
Convergent validity
[ Table 4 ]
All of the depression screening scales were highly correlated with WHODAS 2.0 disability score and the number of days of disability in the preceding month (See Table 4 ). Increasing numbers of previous visits with a health centre were associated with higher scores on the PHQ-9 and the SRQ-20 but not on the PHQ-2 or the Kessler scales.
Construct validity
The PHQ-9 and Kessler 10 were unidimensional on exploratory factor analysis. For these scales, all items loaded onto the resulting factor with an item-factor correlation of 0.35 or more. For the SRQ-20, two factors had Eigenvalues greater than 1.0 but there was substantial cross-loading of items and, therefore, a single factor solution was considered most meaningful. Items 16 (worthlessness) and 18 (fatigue) of the SRQ-20 did not load onto any of the factor models. See Supplementary Figure 1 and Supplementary Tables 2 to 4 .
Misclassification
See Table 5 . In the multivariable model, misclassification of MDD was associated with lower educational level and the presence of physical disability.
[ Table 5 ]
Discussion
In this validation study of brief depression screening questionnaires in PHC settings in The similarity in the psychometric properties of the PHQ-9, SRQ-20, K6 and K10 for detection of MDD is perhaps surprising, although in keeping with a previous head-tohead comparison in India [38] . The PHQ-9 and K10/6 item response categories measure the persistence of symptoms whereas the SRQ-20 item response categories only measure the existence of symptoms, regardless of severity or persistence. In the low-literacy setting of this study it is possible that the potential gains in accuracy were offset by the complexity of the multiple response categories. The reporting time periods also differ between the scales: 30 days for the SRQ-20 and K10/6, and two weeks for the PHQ-9,but this did not result in a higher prevalence of 'probable MDD'
at the optimal cut-off point. Furthermore, the SRQ-20 was designed as a measure of common mental disorders, combining depressive, anxiety and somatic symptoms, and the K10/6 similarly measures non-specific psychological distress whereas the PHQ-9
items closely follow the DSM-IV diagnostic criteria. This finding accords with our previous validation work in Ethiopia [39] , whereby the SRQ-20 was found to be a more valid screening measure of MDD in the postnatal period than a specific depression measure.
The dramatic loss in sensitivity of the PHQ-9 resulting from application of the DSM-IV diagnostic criteria raises concerns about the assumption that the core symptoms of MDD (depressed mood and anhedonia) are the same across cultures. In our study, only 11 out of 18 participants diagnosed as having MDD by the experienced Ethiopian mental health professionals reported either of the core mood symptoms.
Seven out of the other eight people with MDD presented with irritability, which was added to the MINI for our study due to the perceived usefulness in clinical practice in Ethiopia. Irritability is included in DSM-V as a core symptom of depression in young people [40] . In the National Co-morbidity Replication Survey from the US, irritability was a common symptom in people with MDD, although was rarely present in the absence of depressed mood [41] . The addition of irritability to core diagnostic criteria for depression may be more applicable within Ethiopia. Although the area is complex and requires further study, irritability and anger are strongly proscribed in Ethiopian culture and identified readily as deviant states. The same may not be true for sadness, which may provoke less societal reaction. As we have argued previously, the applicability of the concept of anhedonia in a collectivist and religious culture may be limited and contribute to low reporting of this symptom [16] .
The optimal cut-off scores for detecting MDD with the brief questionnaires were lower than those found in validation studies conducted in high-income countries. A recent review of optimal cut-off scores for the PHQ-9 [42] found that PHQ-9 cut-off scores ranging between 8 and 11 performed well in identifying probable MDD. That review included five studies from middle-income countries but no low-income countries. However, studies of PHQ-9 validity in low-income countries from sub-Saharan Africa (Cameroon and Ghana) found low sensitivity at the standard cut-off point [37, 43] . African validation studies of the PHQ-9 which have found higher cutoff points were conducted in well-educated, urban populations [44, 45] .
The performance of the brief depression questionnaires was limited by measurement bias in this study, with misclassification associated significantly with lower educational level and physical disability. Previously we found that depression screening questionnaires that were developed in Western country settings perform better in urban than rural Ethiopia [16, 17] . Mental health literacy, which is related to general levels of education, is likely to play an important part in the performance of self-report depression questionnaires. Bias due to misclassification of symptoms of physical illness as expressions of emotional distress is a recognised problem in applying depression screening scales in a PHC setting with high burden of physical health problems. In this study, somatic symptoms were less discriminating than items that were more cognitive in nature. However, the most frequently endorsed symptoms in people with gold standard MDD were somatic in nature. Furthermore, the symptoms motivating attendance at the PHC facility were all somatic in nature, underlining the importance of somatic symptoms in detection of depression in the PHC setting.
A limitation of the study was that we were unable to evaluate test-retest reliability due to feasibility constraints.
Conclusions
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